期刊文献+

烟酸对实验性动脉粥样硬化兔主动脉骨桥蛋白表达的影响 被引量:3

Effect of Nicotinic Acid on Plaques Formation and Expression of Osteopontin mRNA in Aorta of Experimental Atherosclerosis Rabbit
暂未订购
导出
摘要 目的探讨烟酸对动脉粥样硬化兔主动脉壁骨桥蛋白表达的影响。方法 16只雄性新西兰大白兔给予高脂饮食8周后,随机分为高脂血症组与烟酸组:高脂血症组(n=8)继续饲以高脂饲料6周;烟酸组(n=8)在高脂饮食基础上给予烟酸[200 mg/(kg.d)]6周。另选8只兔给予普通饮食14周作为正常对照组。14周末处死动物进行主动脉病理学检测,采用免疫组织化学染色检测兔主动脉壁骨桥蛋白的表达水平,采用实时定量PCR检测各组兔主动脉壁骨桥蛋白mRNA的表达。结果与正常对照组相比,高脂血症组主动脉内膜厚度和斑块面积显著增加,骨桥蛋白和mRNA表达显著增加(P<0.01)。烟酸组主动脉内膜和斑块面积显著缩小,骨桥蛋白和mRNA表达显著减少(均P<0.01)。相关性分析显示:骨桥蛋白表达量与动脉粥样硬化斑块面积(r=0.821,P<0.01)及内膜厚度(r=0.818,P<0.01)均呈正相关;骨桥蛋白mRNA表达量与动脉粥样硬化斑块面积(r=0.888,P<0.01)及内膜厚度(r=0.874,P<0.01)也均呈正相关。结论烟酸抗动脉粥样硬化作用除与其降脂作用有关外,还可能与其降低骨桥蛋白和mRNA水平有关。 Aim To investigate the effects of nicotinic acid on the atherosclerotic plaques formation and osteopontin (OPN) mRNA expression of aorta. Methods 16 New Zealand white rabbits were fed with high-fat diet for 8 weeks, and then were randomly divided into two groups : ( 1 ) hyperlipidemia group ( n = 8 ) : maintained high-fat diet for 6 weeks ; (2) niacin treatment group ( n = 8) : the same fat diet supplemented with niacin [ 200 mg/( kg · d) ] for 6 weeks. Control group ( n = 8) was fed with normal diet for 14 weeks. At the end of the study, all rabbits were sacrificed to detect the histopathological changes and OPN mRNA expression of the aortas. Results Rabbits fed with high-fat diet showed more aorta endometrial thickness, plaque area and OPN mRNA expression ( all P 〈 0. 01 ). Compared with hyperlipidemia group, rabbits treated with niacin showed less aorta endometrial thickness, plaque area and OPN expression ( all P 〈 0. 01 ). Correlation analysis suggested that expressions of OPN mRNA ( r = 0. 888, P 〈 0. 0! ) and OPN protein ( r = 0. 821, P 〈 0. 01 ) were positively correlated with area of atherosclerotic plaque, expressions of OPN mRNA ( r = 0. 874, P 〈 0. 01 ) and OPN protein ( r = 0. 818, P 〈 0. 01 ) were also positively correlated with intimal thickness of aorta. Con- clusion Niacin' s role of anti-atherosclerosis not only is due to its lipid-lowering effect, but also may be related to its OPN expression-lowering effect.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2013年第2期149-153,共5页 Chinese Journal of Arteriosclerosis
基金 广西青年科学基金资助(桂科青0832049)
关键词 烟酸 动脉粥样硬化 骨桥蛋白 Nicotinic Acid Artery Atherosclerosis Osteopontin
  • 相关文献

参考文献11

  • 1Silverman MG,Blaha MJ,Blumenthal RS. Adjunctive lipid lowering therapy in the era of surrogate endpoints[J].Cardiology in Review,2011,(01):17-22.
  • 2Farmer JA. Nicotinic acid:a new look at an old drug[J].Current Atherosclerosis Report,2009,(02):87-92.
  • 3Witkiewicz W,Czyzewska-Buczynska A,Balasz S. The role of osteopontin in cardiovascular diseases[J].Pol Merkuriusz Lek,2010,(170):79-83.
  • 4Soslow RA,Dannenberg AJ,Rush D. COX-2 is expressed in human pulmonary,colonic,and mammary tumors[J].Cancer,2000,(12):2637-2645.doi:10.1002/1097-0142(20001215)89:12&lt;2637::AID-CNCR17&gt;3.0.CO;2-B.
  • 5Lund SA,Giachelli CM,Scatena M. The role of osteopontin in inflammatory processes[J].J Cell Commun Signal,2009,(3-4):311-322.
  • 6邱志兵,万松.骨桥蛋白与血管再狭窄的关系[J].中华心血管病杂志,2008,36(5):470-472. 被引量:4
  • 7Maziere C,Gomila C,Maziere JC. Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress[J].Free Radical Biology and Medicine,2010,(10):1382-1387.
  • 8陈瑶;汪翼;李倩.烟酸改善实验性肥胖大鼠血脂及血管内皮功能障碍的研究[A]济南:中华医学分会儿科学分会,200864-67.
  • 9Wu ZH,Zhao SP. Niacin promotes cholesterol efflux through stimulation of the PPAR gamma-LXR alpha-ABCA1 pathway in 3T3-L1 adipocytes[J].Pharmacology,2009,(05):282-287.doi:10.1159/000242999.
  • 10Nakamachi T,Nomiyama T,Gizard F. PPAR alpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes[J].Diabetes,2007,(06):1662-1670.

二级参考文献21

  • 1郑向阳,张凯伦,杜心灵,蒋雄刚,刘小斌.骨桥蛋白特异性短发夹RNA抑制大鼠血管平滑肌细胞增殖[J].华中科技大学学报(医学版),2006,35(6):734-736. 被引量:3
  • 2韩梅,张永钢,温进坤.抗骨桥蛋白抗体抑制血管内膜增生的实验研究[J].中国病理生理杂志,2006,22(3):477-480. 被引量:9
  • 3Giachelli CM, Bae N, Almeida M, et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest, 1993,92 : 1686-1696.
  • 4Takahashi K, Takahashi F, Tanabe KK, et al. The carboxylteminal fragment of osteopontln suppresses arginine-glycineasparatic acid-dependent cell adhesion. Biochem Mol Biol Int, 1998,46 : 1081-1092.
  • 5Helluin O, Chan C, Vilaire G, et al. The activation state of αvβ3 regulates platelet and lymphocyte adhesion to intact and thrombin- cleavaged osteopontin. J Biol Chem, 2000,275 : 18337-18343.
  • 6Kart hikeyan G, Bhargava B. Prevention of restenosis after coronary angioplasty. Curr Opin Cardiol,2004,19:500-509.
  • 7Hayden MR, Tyagi SC. Arterial vascular remodeling: the endothelial cell's central role. Mo Med, 1998,95:213-217.
  • 8Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventltial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation ,2002,105:2504-2511.
  • 9Ohmori R, Momiyama Y, Taniguchi H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis,2003,170:333-337.
  • 10Suezawa C, Kusachi S, Murakami T, et al. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med,2005, 145:33-40.

共引文献3

同被引文献27

  • 1沈伟,范维琥,施海明.微球技术在血管新生研究领域中的应用进展[J].心血管病学进展,2007,28(5):763-766. 被引量:3
  • 2Ikeda T, Shirasawa T, Esaki Y, et al. Osteopontin mRNA is ex- pressed by smooth muscle-derived foam cells in human atherosclerotie lesions of the aorta [J]. J Clin Invest, 1993, 92(6) : 2 814-820.
  • 3Wada T, McKee MD, Steitz S, et al. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin [ J ]. Cite Res, 1999, 84(2) : 166-178.
  • 4Berezin AE, Kremzer AA. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus pa- tients with known asymptomatic coronary artery disease [ J ]. Athero- sclerosis, 2013, 229(2) : 475-481.
  • 5Qiu ZB, Xu H, Duan C, et al. Osteopontin is required for angioten- sin II-induced migration of vascular smooth muscle cells [ J ]. Pharmazie, 2012, 67(6) : 553-558.
  • 6Haberl R, Becker A, Leber A, et al. Correlation of coronary calcifi- cation and angiographically documented stenosis in patients with sus- pected coronary artery disease: results of 1764 patients [ J]. J Am Coil Cardiol, 2001, 37(2) : 451-457.
  • 7Nitta K, Ishizuka T, Horita S, et al. Soluble osteopontin and vascu- lar calcification in hemodialysis patients [ J ]. Nephron, 2001, 89 (4) : 455-458.
  • 8Isoda K, Nishikawa K, Kamezawa Y, et al. Osteopontin plays an important role in the development of medial thickening and neointi- real formation [J]. Cire Res, 2002, 91(1): 77-82.
  • 9Speer MY, McKee MD, Guldberg RE, et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla pro- tein-deficient mice: evidence for osteopontin as an inducible inhib- itor of vascular calcification in vivo [ J]. J Exp Ned, 2002, 196 (8) : 1 047-055.
  • 10Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atheroscle- rotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coil Cardiol, 2014, 63 (25PtB) : 2 889-934.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部